- Home
- BDRX vs ADN Comparison
BDRX vs ADN Comparison
Compare BDRX & ADN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BDRX
- ADN
- Stock Information
- Founded
- BDRX 2000
- ADN 2006
- Country
- BDRX United Kingdom
- ADN United States
- Employees
- BDRX N/A
- ADN N/A
- Industry
- BDRX Biotechnology: Pharmaceutical Preparations
- ADN Power Generation
- Sector
- BDRX Health Care
- ADN Utilities
- Exchange
- BDRX Nasdaq
- ADN Nasdaq
- Market Cap
- BDRX 4.3M
- ADN 4.9M
- IPO Year
- BDRX N/A
- ADN N/A
- Fundamental
- Price
- BDRX $6.60
- ADN $5.06
- Analyst Decision
- BDRX
- ADN
- Analyst Count
- BDRX 0
- ADN 0
- Target Price
- BDRX N/A
- ADN N/A
- AVG Volume (30 Days)
- BDRX 33.0K
- ADN 2.5M
- Earning Date
- BDRX 09-29-2025
- ADN 08-12-2025
- Dividend Yield
- BDRX N/A
- ADN N/A
- EPS Growth
- BDRX N/A
- ADN N/A
- EPS
- BDRX N/A
- ADN N/A
- Revenue
- BDRX N/A
- ADN $115,000.00
- Revenue This Year
- BDRX N/A
- ADN $6,528.51
- Revenue Next Year
- BDRX N/A
- ADN N/A
- P/E Ratio
- BDRX N/A
- ADN N/A
- Revenue Growth
- BDRX N/A
- ADN N/A
- 52 Week Low
- BDRX $5.85
- ADN $1.71
- 52 Week High
- BDRX $160.00
- ADN $8.79
- Technical
- Relative Strength Index (RSI)
- BDRX 36.03
- ADN 86.64
- Support Level
- BDRX $6.31
- ADN $4.02
- Resistance Level
- BDRX $7.24
- ADN $5.39
- Average True Range (ATR)
- BDRX 0.39
- ADN 0.75
- MACD
- BDRX 0.04
- ADN 0.29
- Stochastic Oscillator
- BDRX 30.85
- ADN 74.37
About BDRX Biodexa Pharmaceuticals plc
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.
About ADN Advent Technologies Holdings Inc.
Advent Technologies Holdings Inc is an innovation-driven company in the fuel cell and hydrogen technology space, including liquid hydrogen carriers such as methanol. The company develops, manufactures, and assembles complete fuel cell systems and the critical components that determine the performance of hydrogen fuel cells and other energy systems. It serves automotive; aviation and power generation industries. It generates revenue from the sale of fuel cell systems and the sale of MEAs, membranes, and electrodes for specific applications in the fuel cell and energy storage (flow battery) markets.